Top 10 Companies in the (S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) Market (2026): Market Leaders Powering Global Pharmaceutical Development

MARKET INSIGHTS

Global (S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a CAGR of 6.9% during the forecast period.

(S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) is a chiral pyrrolidine derivative featuring a benzyl group and a cyano substituent, widely recognized as a high‑value pharmaceutical intermediate and building block in asymmetric synthesis. Its well‑defined stereochemistry makes it particularly valuable in the development of central nervous system (CNS) drugs, enzyme inhibitors, and other therapeutically active compounds where stereoselectivity is critical to efficacy and safety.

The market is experiencing steady growth driven by rising demand for enantiopure intermediates in pharmaceutical manufacturing and the expanding pipeline of CNS‑targeted drug candidates globally. Furthermore, increasing outsourcing of fine chemical synthesis to contract development and manufacturing organizations (CDMOs) is broadening the compound’s commercial reach. Key suppliers operating in this space include specialized fine chemical and chiral chemistry manufacturers across North America, Europe, and Asia‑Pacific.

(S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) Market – View in Detailed Research Report

🔟 1. Shanghai Longsheng Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity chiral intermediates, custom synthesis, process development

Shanghai Longsheng has a robust asymmetric synthesis platform that delivers enantiomeric excesses above 99% for complex pyrrolidine derivatives. The company’s integrated process‑scale reactors and in‑house chiral HPLC capabilities allow rapid turnaround for API manufacturers.

Sustainability Initiatives:

• Implementation of energy‑efficient flow reactors reducing solvent usage by 30%
• Zero‑waste policy for cyanation steps, achieving <1% by‑product generation
• Certification under ISO 9001 and ISO 14001, aligning with green chemistry guidelines

9️⃣ 2. Hangzhou Keyingchem Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Custom chiral building blocks, rapid scale‑up, analytical support

Keyingchem’s modular synthesis modules enable rapid batch scaling from gram to kilogram volumes while maintaining stereochemical integrity. The firm’s close collaboration with academic laboratories fuels early‑stage discovery projects.

Sustainability Initiatives:

• Use of renewable feedstocks for benzylation reagents
• Closed‑loop solvent recycling system with >90% recovery
• Annual carbon footprint reporting and reduction targets

8️⃣ 3. Jinan Haohua Industry Co., Ltd.

Headquarters: Jinan, China
Key Offering: Multi‑step synthesis, custom purity grades, API support

Haohua’s proprietary chiral pool‑derived routes minimize catalyst usage and offer a cost‑effective alternative to catalytic asymmetric processes, appealing to mid‑sized biotech firms.

Sustainability Initiatives:

• Green solvent selection program reducing hazardous waste
• Investment in biocatalytic pathways for cyanation
• Partnership with local universities on green chemistry research

7️⃣ 4. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Research‑grade chiral intermediates, analytical services, small‑batch supply

Fluorochem’s niche focus on research‑scale synthesis supports academic discovery, with a reputation for delivering high‑purity (≥98%) material in minimal lead times.

Sustainability Initiatives:

• Adoption of green chemistry metrics in all processes
• Reduced‑to‑zero waste policy for cyanation by-products
• Support of European regulatory compliance through detailed CoA and impurity profiling

6️⃣ 5. Combi‑Blocks Inc.

Headquarters: San Francisco, United States
Key Offering: Custom chiral building blocks, rapid synthesis, high‑purity APIs

Combi‑Blocks leverages modular flow chemistry to produce (S)-N‑Benzyl‑3‑cyanopyrrolidine in under 48 hours, with enantiomeric excesses consistently above 99.5%.

Sustainability Initiatives:

• Implementation of continuous flow reactors cutting solvent consumption by 40%
• Zero‑waste cyanation processes using recyclable reagents
• Carbon neutral operations through renewable energy sourcing

5️⃣ 6. AK Scientific, Inc. (AKSCI)

Headquarters: Boston, United States
Key Offering: High‑purity chiral intermediates, custom synthesis, API support

AK Scientific’s asymmetric hydrogenation platform delivers precise stereochemical control, essential for CNS drug development pipelines.

Sustainability Initiatives:

• Investment in renewable hydrogen sources for catalytic processes
• Reduced solvent usage through process intensification
• Compliance with FDA and EMA guidelines for chiral purity documentation

4️⃣ 7. Synthonix Inc.

Headquarters: Seattle, United States
Key Offering: Custom synthesis, analytical support, rapid scale‑up

Synthonix specializes in resolving racemic mixtures via advanced chiral chromatography, offering a cost‑effective route for high‑purity intermediates.

Sustainability Initiatives:

• Use of biodegradable chromatography media
• Closed‑loop solvent recovery systems
• Carbon footprint monitoring and reduction targets

3️⃣ 8. Aromsyn Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: Custom chiral intermediates, process optimization, API support

Aromsyn’s proprietary chiral ligands enhance catalyst turnover, reducing reaction times and increasing yield for (S)-N‑Benzyl‑3‑cyanopyrrolidine.

Sustainability Initiatives:

• Energy‑efficient reactor designs
• Recycling of cyanation by‑products into feedstock
• ISO 9001 and ISO 14001 certifications

2️⃣ 9. Enamine Ltd.

Headquarters: Vienna, Austria
Key Offering: High‑purity chiral intermediates, custom synthesis, analytical services

Enamine’s extensive library of chiral catalysts supports rapid development of new synthetic routes for (S)-N‑Benzyl‑3‑cyanopyrrolidine, catering to both small‑scale research and large‑scale API production.

Sustainability Initiatives:

• Green chemistry training for staff and partners
• Implementation of waste‑to‑energy systems for organic by‑products
• Annual sustainability reporting aligned with EU directives

1️⃣ 10. AstaTech Inc.

Headquarters: Toronto, Canada
Key Offering: Custom chiral synthesis, process scale‑up, analytical support

AstaTech focuses on integrating biocatalytic steps with traditional chemistry to achieve high enantiomeric purity while minimizing environmental impact.

Sustainability Initiatives:

• Biocatalyst development reducing the need for toxic reagents
• Use of renewable solvents and green hydrogen
• Carbon offset programs and renewable energy procurement

Download FREE Sample Report: (S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) Market – View in Detailed Research Report

Get Full Report: (S)-N-Benzyl-3-cyanopyrrolidine (CAS 159063-16-8) Market – View in Detailed Research Report

Outlook

The trajectory of the (S)-N-Benzyl‑3‑cyanopyrrolidine market is shaped by the continued emphasis on stereoselective drug development and the expansion of CDMO services. Manufacturers that can combine rapid scale‑up, high enantiomeric excess, and stringent documentation will secure long‑term contracts with pharmaceutical developers. The convergence of flow chemistry, biocatalysis, and green‑chemistry principles is likely to reduce production costs, making high‑purity intermediates more accessible to mid‑sized biotech firms.

Future Trends

• Adoption of continuous flow platforms for cyanation and benzylation steps, cutting solvent use and waste generation.
• Integration of machine‑learning algorithms for catalyst selection, improving ee outcomes and reducing trial‑and‑error cycles.
• Increasing demand for GMP‑ready, high‑purity intermediates as regulatory agencies tighten chiral purity requirements in API approvals.
• Growth of regional CDMO clusters in Asia‑Pacific and Europe, fostering closer collaboration between fine‑chemical suppliers and pharmaceutical developers.
• Expansion of sustainability reporting and carbon‑neutral production targets across the fine‑chemical supply chain.